Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer

[1]  A. Fairchild,et al.  Radiation-induced esophagitis in lung cancer , 2016, Lung Cancer.

[2]  F. Blanc,et al.  La pneumocystose chez le patient adulte non infecté par le VIH , 2015 .

[3]  G. Kalemkerian,et al.  Running in Place: The 20th Anniversary of the NCCN Small Cell Lung Cancer Guidelines Panel. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  D. Rischin,et al.  Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis , 2015, Leukemia & lymphoma.

[5]  P. Marik,et al.  A Descriptive Study , 2015 .

[6]  O. Decaux,et al.  Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients. , 2014, The American journal of medicine.

[7]  A. Meert,et al.  Acute respiratory distress syndrome in patients with malignancies , 2014, Intensive Care Medicine.

[8]  K. Thursky,et al.  Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reaction. , 2014, Medical mycology.

[9]  D. Boutoille,et al.  Pneumocystis jirovecii pneumonia in HIV-negative patients: A prospective study with focus on immunosuppressive drugs and markers of immune impairment , 2014, Scandinavian journal of infectious diseases.

[10]  A. C. Catanzaro,et al.  Лечение грибковой инфекции у взрослых пациентов в пульмонологической практике и интенсивной терапии , 2011 .

[11]  Lei Wu,et al.  Prediction of radiation pneumonitis in lung cancer patients: a systematic review , 2012, Journal of Cancer Research and Clinical Oncology.

[12]  A. Al-Katib,et al.  Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders. , 2012, Clinical lymphoma, myeloma & leukemia.

[13]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[14]  Ke Wang,et al.  PCR Diagnosis of Pneumocystis Pneumonia: a Bivariate Meta-Analysis , 2011, Journal of Clinical Microbiology.

[15]  F. Derouin,et al.  Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  John W. Wilson,et al.  Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity. , 2011, Diagnostic microbiology and infectious disease.

[17]  N. Ampel,et al.  An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. , 2011, American journal of respiratory and critical care medicine.

[18]  I. Harris,et al.  A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010 .

[19]  Wan Jiancheng,et al.  Screening Pneumocystis carinii pneumonia in non-HIV-infected immunocompromised patients using polymerase chain reaction. , 2009, Diagnostic microbiology and infectious disease.

[20]  J. Kovacs,et al.  Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. , 2009, JAMA.

[21]  John T Brooks,et al.  Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[22]  S. Chevret,et al.  Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. , 2009, Chest.

[23]  É. Azoulay,et al.  Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. , 2007, Chest.

[24]  L. Leibovici,et al.  Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. , 2007, Mayo Clinic proceedings.

[25]  A. Limper,et al.  Current insights into the biology and pathogenesis of Pneumocystis pneumonia , 2007, Nature Reviews Microbiology.

[26]  J. Helweg-Larsen,et al.  Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: A retrospective study 2002–2004 , 2007, Scandinavian journal of infectious diseases.

[27]  L. Mileshkin,et al.  An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital , 2005, British Journal of Cancer.

[28]  A. Limper,et al.  Pneumocystis pneumonia. , 2004, The New England journal of medicine.

[29]  J. Pulvirenti,et al.  Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era. , 2003, AIDS patient care and STDs.

[30]  S. Grossman,et al.  Pneumocystis carinii pneumonia prophylaxis in HIV negative patients with primary CNS lymphoma. , 2003, Cancer treatment reviews.

[31]  M. Robin,et al.  Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  C. Lacroix,et al.  Analysis of Underlying Diseases and Prognosis Factors Associated with Pneumocystis carinii Pneumonia in Immunocompromised HIV-Negative Patients , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[33]  S. Abid,et al.  Radiation-induced and chemotherapy-induced pulmonary injury , 2001, Current opinion in oncology.

[34]  R. Garland,et al.  Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. , 2000, Chest.

[35]  R. Garland,et al.  Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. , 2000, Chest.

[36]  W. Zimmerli,et al.  Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  A. Limper.  Alveolar macrophage and glycoprotein responses to Pneumocystis carinii. , 1998, Seminars in respiratory infections.

[38]  R. Garland,et al.  Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. , 1998, Chest.

[39]  S. Yale,et al.  Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. , 1996, Mayo Clinic proceedings.

[40]  K. Sepkowitz,et al.  Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk. , 1995, Archives of internal medicine.

[41]  K. Whyte,et al.  Discrimination against people with HIVinfection and AIDS , 1994, BMJ.

[42]  K. Sepkowitz.  Pneumocystis carinii pneumonia in patients without AIDS. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  K. Sepkowitz,et al.  Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. , 1992, JAMA.

[44]  D. Richman,et al.  A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. , 1990, The New England journal of medicine.

[45]  P. Cregan,et al.  Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens , 1990, Journal of clinical microbiology.

[46]  R. Aur,et al.  Intensity of immunosuppressive therapy and the incidence of pneumocystis carinii pneumonitis , 1975 .